Joint Venture?https://www.fiercebiotech.com/biotech/biopharma-dealmaking-continues-rise-ma-values-hold-steady-pwc
With all the hype about big pharma looking for new innovative drugs and expanding their pipeline, one has to ask what we are doing wrong. Our new CEO is allusive and seems to talk a lot and deliver nothing.